SWISS-APERO is the first randomized clinical trial comparing Amulet with the new generation Watchman FLX device in terms of residual left atrial appendage (LAA) patency
Read more
Home »
SWISS-APERO is the first randomized clinical trial comparing Amulet with the new generation Watchman FLX device in terms of residual left atrial appendage (LAA) patency
Read moreSkip to: What is Takayasu's arteritis? What causes Takayasu's arteritis and who is at risk? Management and diagnosis of Takayasu's arteritis using non-invasive imaging Summary
Read more